What Researchers Did
Researchers conducted a prospective, double-controlled study comparing hyperbaric oxygen therapy, daily tadalafil, and no treatment for erectile dysfunction over one month.
What They Found
Both hyperbaric oxygen therapy and daily tadalafil significantly increased mean IIEF-5 scores (p < 0.001 for both) compared to no treatment (p = 0.496). There was no significant difference in IIEF-5 scores between the hyperbaric oxygen and tadalafil groups (p = 0.166). However, patients with peripheral vascular disease did not improve with hyperbaric oxygen treatment (p = 0.285).
What This Means for Canadian Patients
Hyperbaric oxygen therapy could be a viable alternative for Canadian patients with erectile dysfunction, especially if oral medications are unsuitable. However, patients with peripheral vascular disease may not benefit from this treatment option.
Canadian Relevance
This study does not have a direct Canadian connection. Nevertheless, the findings may still be relevant to Canadian healthcare providers treating erectile dysfunction.
Study Limitations
A limitation of this study is the short one-month treatment and follow-up duration, which may not reflect long-term efficacy.